Novel variants and clinical symptoms in four new ALG3‐CDG patients, review of the literature, and identification of AAGRP‐ALG3 as a novel ALG3 variant with alanine and glycine‐rich N‐terminus

Published on May 8, 2019in Human Mutation4.453
· DOI :10.1002/humu.23764
Nastassja Himmelreich4
Estimated H-index: 4
(Heidelberg University),
Bianca Dimitrov1
Estimated H-index: 1
(Heidelberg University)
+ 21 AuthorsChristian Thiel8
Estimated H-index: 8
(Heidelberg University)
  • References (30)
  • Citations (1)
📖 Papers frequently viewed together
12 Authors (Timo Imbach, ..., Thierry Hennet)
54 Citations
13 Citations
4 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Carlos R. Ferreira (NIH: National Institutes of Health)H-Index: 14
#2Clara D.M. van Karnebeek (UBC: University of British Columbia)H-Index: 22
Last. Nenad Blau (Boston Children's Hospital)H-Index: 56
view all 4 authors...
We propose a nosology for inborn errors of metabolism that builds on their recent redefinition. We established a strict definition of criteria to develop a self-consistent schema for inclusion of a disorder into the nosology. We identified 1015 well-characterized inborn errors of metabolism described in the literature. In addition, there are 111 less well-characterized conditions that may be inborn errors but do not meet strict criteria for inclusion in the current nosology. We provide a master ...
15 CitationsSource
#1Benedikt Hacker (University of Mainz)H-Index: 1
#2Christoph Schultheiß (University of Mainz)H-Index: 1
Last. Ursula Kurzik-Dumke (University of Mainz)H-Index: 12
view all 3 authors...
1 CitationsSource
#1Benedikt Hacker (University of Mainz)H-Index: 1
#2Christoph Schultheiß (University of Mainz)H-Index: 1
Last. Ursula Kurzik-Dumke (University of Mainz)H-Index: 12
view all 4 authors...
2 CitationsSource
#1Bobby G. Ng (DI: Discovery Institute)H-Index: 6
#2Hudson H. Freeze (DI: Discovery Institute)H-Index: 60
Congenital disorders of glycosylation (CDG) are a rapidly expanding group of metabolic disorders that result from abnormal protein or lipid glycosylation. They are often difficult to clinically diagnose because they broadly affect many organs and functions and lack clinical uniformity. However, recent technological advances in next-generation sequencing have revealed a treasure trove of new genetic disorders, expanded the knowledge of known disorders, and showed a critical role in infectious dis...
28 CitationsSource
#1Bing Liu (Dalian Medical University)H-Index: 8
#2Xiaolu Ma (Dalian Medical University)H-Index: 1
Last. Li Jia (Dalian Medical University)H-Index: 21
view all 6 authors...
Drug-resistance is a major problem in acute myeloid leukemia (AML) chemotherapy. Aberrant changes in specific N-glycans have been observed in leukemia multidrug resistance (MDR). MicroRNAs (miRNAs) and long non coding RNAs (lncRNAs) act as key players in the development of AML resistance to chemotherapy. In the present study, the N-glycan profiles of membrane proteins were analyzed from adriamycin (ADR)-resistant U937/ADR cells and sensitive line U937 cells using mass spectrometry (MS). The comp...
8 CitationsSource
#1Yongde YangH-Index: 1
#2Yanlin ZhouH-Index: 1
Last. Mengyuan WangH-Index: 1
view all 6 authors...
3 CitationsSource
We retrospectively reviewed Saudi patients who had a congenital disorder of glycosylation (CDG). Twenty-seven Saudi patients (14 males, 13 females) from 13 unrelated families were identified. Based on molecular studies, the 27 CDG patients were classified into different subtypes: ALG9-CDG (8 patients, 29.5%), ALG3-CDG (7 patients, 26%), COG6-CDG (7 patients, 26%), MGAT2-CDG (3 patients, 11%), SLC35A2-CDG (1 patient), and PMM2-CDG (1 patient). All the patients had homozygous gene mutations. The c...
6 CitationsSource
#1Romain Péanne (Katholieke Universiteit Leuven)H-Index: 6
#2Pascale de Lonlay (Necker-Enfants Malades Hospital)H-Index: 41
Last. Jaak Jaeken (Katholieke Universiteit Leuven)H-Index: 43
view all 12 authors...
Abstract The survey summarizes in its first part the current status of knowledge on the Congenital Disorders of Glycosylation (CDG) with regard to their phenotypic spectrum, diagnostic and therapeutic strategies, and pathophysiology. It documents the clinical and basic research activities, and efforts to involve patients and their families. In the second part, it tries to look into the future of CDG. More specific biomarkers are needed for fast CDG diagnosis and treatment monitoring. Whole genom...
43 CitationsSource
#1Laureline LepaisH-Index: 1
#2David Cheillan (University of Lyon)H-Index: 11
Last. Massimiliano Rossi (French Institute of Health and Medical Research)H-Index: 15
view all 9 authors...
Congenital disorders of glycosylation (CDG) are a group of inborn errors of metabolism presenting with heterogeneous multisystemic clinical manifestations. To date, more than 60 different types of CDG have been reported. ALG3-CDG is very rare, with only nine patients described so far. We report two affected siblings presenting prenatally with skeletal abnormalities associated with dysmorphic features, cerebellar vermis hypoplasia, corpus callosum agenesis, hepatic fibrosis and poor prognosis. Th...
11 CitationsSource
#1Agata Fiumara (University of Catania)H-Index: 26
#2Rita Barone (University of Catania)H-Index: 26
Last. Jaak Jaeken (Katholieke Universiteit Leuven)H-Index: 43
view all 5 authors...
Congenital disorders of glycosylation (CDG) are a constantly growing group of genetic defects of glycoprotein and glycolipid glycan synthesis. CDGs are usually multisystem diseases, and in the majority of patients, there is an important neurological involvement comprising psychomotor disability, hypotonia, ataxia, seizures, stroke-like episodes, and peripheral neuropathy. To assess the incidence, among early-onset epileptic encephalopathies (EOEE), of patients with identified congenital disorder...
9 CitationsSource
Cited By1
#1Brian M. Gilfix (MUHC: McGill University Health Centre)H-Index: 15
1 CitationsSource